The Global Advanced Empty Capsule Industry is predicted to be worth USD 905.6 million in 2023 and is projected to register a CAGR of 7.4% by 2033. Demand initially expanded at a market CAGR of 7.3% between 2018 and 2022.
The projected growth of the Global Advanced Empty Capsule Industry is initially driven by the surging prevalence of chronic illnesses and an aging population. Moreover, the global market participants are likely to benefit from increased research and development efforts in the healthcare industry to enhance treatments.
Accelerated technological development and rising demand for in-home care surge the demand for advanced empty capsules. Market revenue streams are likely to reach new heights when paired with other variables, like customized offerings.
Market growth comes with several challenges; for instance, the global market is anticipated to be restrained by the restricted supply of raw materials needed to produce empty capsules.
During the projected period, the social stigma associated with raw materials originating from animals is also anticipated to impact sales of advanced empty capsules.
Global Advanced Empty Capsule Industry Key Takeaways
- By 2033, the advanced empty capsule market in the United Kingdom is likely to expand, with a CAGR of 5.1%.
- By 2033, the advanced empty capsule market in Russia is likely to expand, with a CAGR of 7.3%
- The advanced empty capsule was significantly expanding, with a size of US$ 844.2 million in 2022.
- In 2022, Europe expanded in the global advanced empty capsule business with a share of 67.5%.
- In 2022, Germany expanded significantly in the advanced empty capsule business, with an expected share of 21%.
- By 2033, India is projected to expand significantly in the advanced empty capsule, with a share of 7.9%.
- In 2023, Australia is likely to develop significantly in the advanced empty capsule sector, with an expected share of 11.9%.
- In 2022, the oral capsules segment expanded in the market with a significant share of 89.43% and is expected to hold a top spot in the market regarding product type.
- Based on the raw material, the animal source segment dominated the industry in 2022, with a share of 66.58%.
Competitors Winning Strategies
Regional & local businesses and advanced empty capsule start-ups are fiercely vying for market share and promoting innovation for sophisticated empty capsules. Constant quality control, product improvement, new launches, and strategic alliances are vital tactics these businesses use to keep themselves competitive. This is done to meet the rising demand for high-tech empty capsules worldwide.
Recent Developments in the Global Advanced Empty Capsule Industry:
- In May 2022, Capsugel introduced a white firm gelatin capsule devoid of titanium dioxide (TiO2-free), which satisfies the need for such meals in the European Union.
- The Sheung brand created EmboCaps® on June 21, 2019. A rigid capsule called the Embocaps®LP+ was designed primarily to store liquids and fine particles. Several gelatin, vegetarian, and delayed-release versions of the Embocaps® LP+ are available.
Key Players from the Global Advanced Empty Capsule Industry:
- Capsugel (Lonza)
- ACG Worldwide
- Medi-Caps Limited
- Sunil Healthcare Limited
- Roxlor LLC
- CapsCanada Corporation
- Suheung Co., Ltd.
- Bright Pharma Caps
- STERIS Plc
- Fuji Capsule Co. Ltd.
- QUALICAPS
Global Advanced Empty Capsule Industry Key Segments
By Product Type:
- Oral Capsules
- Dry formulation
- Immediate-release capsules
- Delayed-release capsules
- Time delayed release capsules
- Acid-resistant capsules
- Enteric capsules
- Liquid formulation
- Dry formulation
- Inhalation Capsules
By Raw Material:
- Animal Source
- Contract Type-A (Pork Skin
- Type-B Gelatin (Animal Bones & Calf Skin)
- Fish Bone Gelatin
- Vegetarian-based
- HydroxyPropyl Methyl Cellulose (HPMC)
- Starch
- Pullulan
By Capsules Size:
- Size “000” Capsules
- Size “00” Capsules
- Size “0” Capsules
- Size “1” Capsules
- Size “2” Capsules
- Size “3” Capsules
- Size “4” Capsules
- Size “5” Capsules
By End User:
- Pharmaceutical
- Nutraceutical & Cosmetic
- CROs
- CMOs
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube